Vanguard Group’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.85M | Sell |
|
|||||
|
2022
Q3 | $1.6M | Sell |
|
|||||
|
2022
Q2 | $5.57M | Buy |
|
|||||
|
2022
Q1 | $2.12M | Sell |
|
|||||
|
2021
Q4 | $3.75M | Buy |
|
|||||
|
2021
Q3 | $5.45M | Sell |
|
|||||
|
2021
Q2 | $6.64M | Buy |
|
|||||
|
2021
Q1 | $5.72M | Buy |
|
|||||
|
2020
Q4 | $3.83M | Buy |
|
|||||
|
2020
Q3 | $569K | Sell |
|
|||||
|
2020
Q2 | $649K | Sell |
|
|||||
|
2020
Q1 | $417K | Hold |
|
|||||
|
2019
Q4 | $709K | Hold |
|
|||||
|
2019
Q3 | $1.57M | Sell |
|
|||||
|
2019
Q2 | $1.86M | Sell |
|
|||||
|
2019
Q1 | $5.81M | Buy |
|
|||||
|
2018
Q4 | $5.75M | Buy |
|
|||||
|
2018
Q3 | $6.62M | Buy |
|
|||||
|
2018
Q2 | $4.83M | Buy |
|
|||||
|
2018
Q1 | $5.55M | Buy |
|
|||||
|
2017
Q4 | $3.65M | Buy |
|
|||||
|
2017
Q3 | $3.23M | Buy |
|
|||||
|
2017
Q2 | $794K | Buy |
|